Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Lifecore Biomedical, Inc. (LFCR) had Days Sales in Receivables of 75.42 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$23.19M |
|
$-15.93M |
|
$18.73M |
|
$4.46M |
|
$27.86M |
|
$-4.67M |
|
$-10.27M |
|
$-14.94M |
|
$-14.94M |
|
$-14.98M |
|
$-14.98M |
|
$-14.98M |
|
$-14.98M |
|
$-4.67M |
|
$-2.36M |
|
37.48M |
|
37.48M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$77.64M |
|
$125.51M |
|
$147.86M |
|
$225.50M |
|
$20.50M |
|
$147.78M |
|
$184.22M |
|
$204.72M |
|
$-28.44M |
|
$6.90M |
|
$20.78M |
|
37.48M |
|
| Cash Flow Statement Financials | |
$4.70M |
|
$-1.12M |
|
$-0.26M |
|
$17.47M |
|
$20.80M |
|
$3.33M |
|
$1.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.79 |
|
-- |
|
-- |
|
0.88 |
|
7.11 |
|
19.24% |
|
-20.14% |
|
-20.14% |
|
-- |
|
-64.40% |
|
-68.70% |
|
$3.58M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.67 |
|
1.19 |
|
|
Days Sales in Receivables |
75.42 |
52.68% |
|
-217.20% |
|
-6.64% |
|
-8.89% |
|
$0.55 |
|
$0.10 |
|
$0.13 |
|